gene therapy summit 2022

2021/05/21

Develop, Validate & Implement Cell-Based & Biophysical Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products at Scale, The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. Congo (+242) El Salvador (+503) Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively. We will provide you with full supporting documentation after the event and assist you in getting the claim completed. Sri Lanka (+94) Spain (+34) Across four days, this meeting will unite 500+ leading experts in Boston from innovative biotechs, large pharma, academia, and key service provider companies, delivering actionable insights and valuable networking opportunities to accelerate gene therapy progress. Pleasure to find opportunities for cross functional learning amongst peers. MA, 02210. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. 239 Vauxhall Bridge Rd, Crecia Magee, President & Principal Talent Executive. E:info@hansonwade.com, Westin Boston Seaport, Croatia (+385) Italy (+39) Luxembourg (+352) Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene. Denmark (+45) Burkina Faso (+226) See our Privacy Policy to learn more about how we use data. Crecia Magee, President & Principal Talent Executive, PharmaFinders, T: +1 617 455 4188 Kyrgyzstan (+996) With our extensive marketing experience and strategy, your partnership with Advancing Gene Therapy will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. Ireland (+353) If you do not have an accounts department or need help with the PIC claim, our staff will be very happy to assist. Marshall Islands (+692) Sr. Director Analytical Assay development, T: +1 617 455 4188 Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

Bermuda (+1441) Norfolk Islands (+672) More than 750 trials of CGTs in almost 30,000 patients were underway as of June 2020, and CGT products account for some 12 percent of the pharmaceutical industrys clinical pipeline and at least 16 percent of its preclinical pipeline. Copyright EquipGlobal 2017 All Rights Reserved, Vice President and Head, Process Development & MSAT, Global Regulatory Affairs Associate Project Lead, Associate Vice President Associate Vice President, Head, Cell Therapies and Analytical, http://www.iras.gov.sg/irasHome/uploadedFiles/Quick_Links/Tax_forms/Business_and_employers/Cash%20Payout%20Application%20Form_B2011_final.xls, http://www.iras.gov.sg/irashome/picredit.aspx, Learn and benchmark yourself with leading cell & gene therapy experts so that, Select, register and pay for your conference/training course of your choice. Australia (+61) There are however several challenges which needs to be overcome and debated including manufacturing processes, scalability, regulatory compliance, pharmacovigilance & risk management, post-marketing activities, commercialization & market access, and patient evaluation & side-effect management amongst others. Guatemala (+502) Estonia (+372) Micronesia (+691) We have sent an email with the event details to your colleague. Boston, The Gene Therapy Analytical Development 2021 conference contained a wealth of content from many industry insiders and had information indispensable to the analytical drug development process. NanoSomiX Inc, Senior Director, Head of Analytical Development, Associate Director, Analytical Development, Associate Director, NGS Leader, Genomics Medicine Unit CMC, Senior Director, Analytical Sciences & Technology, 10% Discount 3 Passes Location: Hilton Boston Back Bay, 40 Dalton St , Boston, MA 02115 , USA, Start date: Norway (+47) Haiti (+509) China (+86) If you are a registered business in Singapore, you can enjoy huge huge tax savings in the form of cash payouts and/or tax deductions when you invest in training of employees. Bahrain (+973) By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information. Virgin Islands - US (+1340) Enriching and inspiring experience, an highly effective and interactive digital event with thought leaders sharing insights, experiences and vision on the key strategic role of Medical Affairs in delivering gene therapy to patients. Eritrea (+291) Aruba (+297) By continuing to use this site you consent to the use of cookies, unless disabled from your browser. Argentina (+54) Senegal (+221) In this context, the 2nd Annual Gene Therapy Patient Engagement Summit will unite patient advocacy and engagement leaders from gene therapy and gene editing drug developers, patient groups and patients themselves to address the specific challenges of genetic therapy patient engagement, generating actionable insights through detailed case studies and open, honest discussions. Across three carefully curated days, this streamlined one-track summit will unite key gene therapy leaders from large pharma to ground-breaking biotech, academics to exciting service providers, all with the purpose of paving a way forward to successfully launch gene therapy products in Europe. Seychelles (+248) Comoros (+269) Monaco (+377) Mali (+223) The real cost of inefficiency and why digitization pays for itself. Please send your room requests to sachin.sravan@bsc.events with the subject line "Accommodation During AGT-2023". The meeting will provide conference attendees updates on recent gene therapy innovations from vector designs to product launch. Cook Islands (+682) Turkmenistan (+7) Kazakhstan (+7) Continuous training and upgrading of your employees is key to the success of your organization. Solomon Islands (+677) As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the, This years summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma and academia to continue to, Whether you are focusing on specific characterization methods, enhancing your genome sequencing, advancing your understanding of full and partial particles, or advancing your early-stage bioassays, with 4 tracks, 8 pre-conference workshops and a post-conference focus day, the, Post-Conference Focus Day: Non-AAV Vectors. Gabon (+241) It brings together leading biotech and pharma industry experts, academicians, and decision makers who are passionate about addressing major global issues by turning ideas into solutions. Focused specifically on enhancing your gene therapy comparability approach, this event will ensure you can maintain safety, quality, consistency and efficacy while adapting manufacturing processes, methods and platforms, to satisfy regulatory demands and avoid costly delays to clinical programs.

All cancellations must be sent by email at. Lithuania (+370) CTRL + SPACE for auto-complete. Bolivia (+591) Reunion (+262) Gene Therapy Pipeline: Targets and Challenges. Belize (+501)

Guyana (+592) Have a negative COVID-19 test result from an FDA-authorized over-the-counter antigen test within 24 hours prior to arriving at the event. Head of Biologics, Biotechnology, and Advanced Therapies, Lead Separation Methods, Gene Therapy Process Development, Head of Gene Therapy Technical Product Development, Vice President, Analytical Chemistry & Site Head Boulder, Senior Manager Field Marketing Centrifugation Europe, T: +44 (0)20 3141 8700 United Arab Emirates (+971) Hanson Wade's goal is to accelerate progress within organisations and across industries. Hanson Wade's goal is to accelerate progress within organisations and across industries. For more information visit http://www.iras.gov.sg/irashome/picredit.aspx. Gambia (+220) Significant investment is going into this sector. Welcome to the 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022, Gain European Regulatory Clarity to Progress Efficient & Robust Gene Therapies for Rare Disease. St. Kitts (+1869) Namibia (+264) You also receive our free newsletter. Macedonia (+389) Download the full event guide to see the complete speaking list and content in store for 2022. From the first approved oligonucleotide-based therapy to the success of CAR-T cell therapies, followed by the recent in-vivo gene therapies and the emerging gene editing Saudi Arabia (+966) Hong Kong (+852) Therapy Event Series have said: "I found the presenters and participant patient engagement knowledge superb, as was their willingness to share. Why digitization is a must for competitive manufacturing. Jamaica (+1876) Bosnia Herzegovina (+387) Kiribati (+686) Guadeloupe (+590) Cuba (+53) Nauru (+674) Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Looking to the future, biopharmaceutical , biotech companies, and other stakeholders, including regulators and researchers will need to collaborate to develop a new pipeline of research from biological concept to medical practice. Across four days of curated content, incorporating detailed case studies from leading CMC, Regulatory, Analytical and Process Development experts, this is your opportunity to gain a hands-on, practical insight into exactly what it takes to execute successful comparability studies. CHI has instituted mandatory health and safety protocols for all in-person participants. Brunei (+673) The 2023 Advancing Gene Therapy conference will be held in Hyatt Regency Boston, MA. As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, View the 2022 event guide to see what you missed. Bahamas (+1242) Kenya (+254) French Guiana (+594) Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Gibraltar (+350) Malta (+356) Hanson Wade's goal is to accelerate progress within organisations and across industries. Pleasure to find opportunities for cross functional learning amongst peers. Fiji (+679) Sweden (+46) Thank you. The Vector Development for Cell and Gene Therapy Summit is North Americas only event focused exclusively on addressing challenges in vector improvement for both ex vivo and in vivo approaches. The past five years have been a critical turning point for gene therapy. E:info@hansonwade.com. Martinique (+596) You will be asked your results at registration. Take the opportunity to meet industry leaders and subject experts; and enhance your network globally through the networking events. Costa Rica (+506)

engineering, analytics, immunogenicity assessments, preclinical development and clinical translation, to help accelerate next generation gene therapy development. Integrate the Patient Voice to Develop Safer & More Effective Gene Therapies That Are Meaningful to Patients, Join us to hear directly from companies and institutions including. Vietnam (+84) Guinea (+224) Algeria (+213) The rooms are available until March 3rd, 2023. Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Paraguay (+595) Benin (+229) Palau (+680) Contact No: +44 (0)20 3696 2920 We are very happy to be able to offer you a discounted accommodation in the Hyatt Regency Boston Woburn from April 17 - 19, 2023. Brazil (+55) Singapore (+65) Rwanda (+250) ", Lots of useful information and good variety of perspectives., Exciting new way of participating in scientific conference and discussion., Incredibly positive and eye-opening experience for a scientist new to the field., Associate Director, Global Patient Advocacy & Engagement, Deputy Director, Officer of Rare Diseases Research, T: +44 (0)20 3141 8700 Hanson Wade's goal is to accelerate progress within organisations and across industries. Kuwait (+965) For further information around Health and Safety onsite, please visit our FAQs page here or for more information on the B Together Policy, please see here. This policy requires individuals to show you proof of vaccination against COVID-19 in order to gain admittance to the conference venue. High quality speakers, outstanding job., T: (+1) 617 455 4188 Manager, Business DevelopmentT:781.972.5452jgerardi@healthtech.com, Bethany GrayDirector of Product MarketingT: 781.972.5494bgray@healthtech.com, 250 First Avenue, Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425 Cayman Islands (+1345) E:info@hansonwade.com. St. Lucia (+1758) #VSBOSTON provides an iconic platform where science, and business converge. Hanson Wade's goal is to accelerate progress within organisations and across industries. Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Across four days of curated content, incorporating detailed case studies from leading CMC, Regulatory, Analytical and Process Development experts, The health, safety and well-being of our community remains our highest priority, therefore, all attendees will be required to complete a health declaration prior to attending the event, as well as comply with the City of Bostons B Together policy. The massive success of cell and gene therapies in recent years has made the need for effective, large scale vector engineering greater than ever. Kisaco Research produces, designs and hosts B2B industry conferences and exhibitions. Azerbaijan (+994) Ukraine (+380) VP Medical and Patient Affairs, Encoded Therapeutics, Inc. SVP of Global Commercial Development & TA Strategy, CSL Behring. Maldives (+960) Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. File your receipt (which we will email you), record of attendance (which we will provide you at the event) and the completed PIC form with your accounts department which they will submit to IRAS to process the claim. Whether youre targeting the entire conference community of life sciences, pharmaceutical, clinical, healthcare, and IT professionals, a topic-specific community, a specific individual, or high-level decision makers, we offer a variety Continuing advances in cell and gene therapy (CGT) are transforming how we treat and potentially cure certain diseases. Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. of methods to access our esteemed delegates. Switzerland (+41) Email us today at enquiry@equip-global.com! Djibouti (+253) Eleonora Russo, Director Rare Disease Medical. Bulgaria (+359) Provide proof of full vaccination against COVID-19. Ethiopia (+251) 15% Discount 4 Passes Mauritania (+222) Myanmar (+95) Central African Republic (+236) The health, safety and well-being of our community remains our highest priority, therefore, all attendees will be required to complete a health declaration prior to attending the event, as well as comply with the City of Bostons B Together policy. Poland (+48) Registration is free and allows users complete access to all sections of the site, including archived news items. Join us to hear directly from companies and institutions including Spark Therapeutics, Ultragenyx, FDA, Global Genes, and CRISPR Therapeutics on key topics including managing expectations across gene therapy development, navigating patient input on one-time transformative treatments with novel clinical trial designs combined with extensive follow-ups, and developing educational materials on gene therapy to raise awareness in collaboration with patient advocacy organizations. Nigeria (+234) As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4th Annual Gene Therapy Analytical Development as an analytical scientist has never been so important. Event Organizer: Kisaco Research Egypt (+20) Be a part of the platform to hear first about the latest news in gene therapy and update your knowledge. Attendees of the Gene Honduras (+504) Yemen (North)(+969) to: Bringing Together Vector Engineers and Scientists to Accelerate Gene Therapy Development. Chile (+56) Turks & Caicos Islands (+1649) USA (+1) E: chi@healthtech.com. Drivers of these advances will be discussed including the rapid pace of change from biotechnology, pharmaceutical, manufacturing and CROs with preclinical, non-clinical and trial expertise. Lebanon (+961) Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.